Of potentially more relevance and utility in identifying those at risk from COVID-19 would be to examine the large, well-established prospective epidemiological cohort studies which have focused on precise measurement of insulin sensitivity [for example the EGIR RISC study (54)] and determine whether this predicts COVID-19 incidence or severity. The gene discussed is INS; the disease is COVID-19.